8CX9
Structure of the SARS-COV2 PLpro (C111S) in complex with a dimeric Ubv that inhibits activity by an unusual allosteric mechanism
Summary for 8CX9
Entry DOI | 10.2210/pdb8cx9/pdb |
Descriptor | Papain-like protease nsp3, Ubiquitin variant UbV.CV2.1, ZINC ION, ... (6 entities in total) |
Functional Keywords | inhibitor complex, allosteric inhibition, viral protein, viral protein-signaling protein complex, viral protein/signaling protein |
Biological source | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2) More |
Total number of polymer chains | 12 |
Total formula weight | 238772.80 |
Authors | Singer, A.U.,Slater, C.L.,Patel, A.,Russel, R.,Mark, B.L.,Sidhu, S.S. (deposition date: 2022-05-20, release date: 2023-01-25, Last modification date: 2023-10-25) |
Primary citation | van Vliet, V.J.E.,Huynh, N.,Pala, J.,Patel, A.,Singer, A.,Slater, C.,Chung, J.,van Huizen, M.,Teyra, J.,Miersch, S.,Luu, G.K.,Ye, W.,Sharma, N.,Ganaie, S.S.,Russell, R.,Chen, C.,Maynard, M.,Amarasinghe, G.K.,Mark, B.L.,Kikkert, M.,Sidhu, S.S. Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site. Plos Pathog., 18:e1011065-e1011065, 2022 Cited by PubMed: 36548304DOI: 10.1371/journal.ppat.1011065 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3.5 Å) |
Structure validation
Download full validation report